haloperidol has been researched along with Epilepsy, Absence in 10 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Epilepsy, Absence: A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736)
Excerpt | Relevance | Reference |
---|---|---|
"The effects of topiramate, a novel antiepileptic drug, on tonic and absence-like seizures in spontaneously epileptic rats (SER; zi/zi, tm/tm) and on sound-induced seizures in DBA/2 mice were investigated." | 7.69 | Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice. ( Ishihara, K; Ishii, A; Kanda, T; Nakamura, J; Sasa, M; Serikawa, T; Tamura, S; Yamada, J, 1994) |
"The effects of topiramate, a novel antiepileptic drug, on tonic and absence-like seizures in spontaneously epileptic rats (SER; zi/zi, tm/tm) and on sound-induced seizures in DBA/2 mice were investigated." | 3.69 | Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice. ( Ishihara, K; Ishii, A; Kanda, T; Nakamura, J; Sasa, M; Serikawa, T; Tamura, S; Yamada, J, 1994) |
"Haloperidol treatment during pre- and post-natal period affects maternal behavior and this may have long-term effects on the offspring." | 1.37 | The effect of haloperidol on maternal behavior in WAG/Rij rats and its consequences in the offspring. ( Dobryakova, YV; Dubynin, VA; Luijtelaar, GV, 2011) |
"In haloperidol-treated epileptic rats, LCMRglc decreased to levels comparable to those measured in untreated control rats." | 1.28 | Mapping of cerebral energy metabolism in rats with genetic generalized nonconvulsive epilepsy. ( Boyet, S; Marescaux, C; Nehlig, A; Vergnes, M, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dobryakova, YV | 1 |
Dubynin, VA | 1 |
Luijtelaar, GV | 1 |
Bosnyakova, D | 1 |
Gabova, A | 1 |
Kuznetsova, G | 1 |
Obukhov, Y | 1 |
Midzyanovskaya, I | 1 |
Salonin, D | 1 |
van Rijn, C | 1 |
Coenen, A | 1 |
Tuomisto, L | 1 |
van Luijtelaar, G | 1 |
Nakamura, J | 1 |
Tamura, S | 1 |
Kanda, T | 1 |
Ishii, A | 1 |
Ishihara, K | 1 |
Serikawa, T | 1 |
Yamada, J | 1 |
Sasa, M | 1 |
Nehlig, A | 3 |
Vergnes, M | 3 |
Marescaux, C | 3 |
Boyet, S | 2 |
Waydelich, R | 1 |
Hirsch, E | 1 |
Charbonne, R | 1 |
Seylaz, J | 1 |
de Bruin, NM | 2 |
van Luijtelaar, EL | 3 |
Jansen, SJ | 1 |
Cools, AR | 2 |
Ellenbroek, BA | 2 |
Midzianovskaia, IS | 1 |
Kuznetsova, GD | 1 |
Coenen, AM | 1 |
Spiridonov, AM | 1 |
Arushanian, EB | 1 |
Avakian, RM | 1 |
10 other studies available for haloperidol and Epilepsy, Absence
Article | Year |
---|---|
The effect of haloperidol on maternal behavior in WAG/Rij rats and its consequences in the offspring.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anti-Dyskinesia Agents; Brain Waves; D | 2011 |
Time-frequency analysis of spike-wave discharges using a modified wavelet transform.
Topics: Algorithms; Anesthetics, Dissociative; Animals; Anti-Allergic Agents; Anticonvulsants; Data Interpre | 2006 |
Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroencephalogr | 1994 |
Cerebral energy metabolism in rats with genetic absence epilepsy is not correlated with the pharmacological increase or suppression of spike-wave discharges.
Topics: Action Potentials; Animals; Autoradiography; Brain; Electroencephalography; Energy Metabolism; Epile | 1993 |
Absence seizures induce a decrease in cerebral blood flow: human and animal data.
Topics: Animals; Anticonvulsants; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Cerebral Cortex; Cere | 1996 |
Dopamine characteristics in different rat genotypes: the relation to absence epilepsy.
Topics: Action Potentials; Animals; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Anta | 2000 |
Electrophysiological and pharmacological characteristics of two types of spike-wave discharges in WAG/Rij rats.
Topics: Action Potentials; Animals; Apomorphine; Biological Clocks; Cerebral Cortex; Disease Models, Animal; | 2001 |
Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
Topics: Amphetamine; Animals; Apomorphine; Arousal; Dopamine; Epilepsy, Absence; Genotype; Haloperidol; Limb | 2001 |
[Participation of monoaminergic mechanisms and the striatum in the development of "petit mal" induced by corazole].
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Biogenic Amines; Chlorpromazine; Corpus Striatum; Drug In | 1978 |
Mapping of cerebral energy metabolism in rats with genetic generalized nonconvulsive epilepsy.
Topics: Animals; Brain; Brain Mapping; Disease Models, Animal; Electroencephalography; Energy Metabolism; Ep | 1992 |